Tags

Journalists: Please sign up for PEERmedia to receive all our recent releases, documents and other information that affect not only public employees, but the public at large.


Appeals Backlog at MSPB Tops 1,100, Group Says

From: FedWeek

"A group that advocates for federal employees involved in environmental matters has reported that the appeals backlog at MSPB now exceeds 1,100, with some of the cases…

The Energy 202: Interior Lacks Permanent Leaders for Key Agencies Controlling Roughly 500 Million Acres of Public Land

From: The Washington Post

"To not run afoul of that vacancies law, Zinke gave 10 acting directors the power to carry out duties “not required by statute or regulation to be performed…

More Tumult at America’s Chemical Safety Agency

From: Chemistry World

"The managing director of the embattled US Chemical Safety Board (CSB), who had been on paid administrative leave since June 2015 over accusations of mismanagement…

EPA Given More Time on Climate Comments

From: Politico

"EPA has until August to hand over scientific information to Public Employees for Environmental Responsibility under a previous court order related to its FOIA request…

More Bayview, Hunters Point Residents Added To $27 Billion Suit Against Tetra Tech

From: SF Gate

"Attorneys representing 38,000 residents of San Francisco's Hunters Point and Bayview neighborhoods in a lawsuit against Tetra Tech, the firm hired by the U.S. Navy to…


News Releases

MOST U.S. WATERS ARE POLLUTED AND GETTING DIRTIER

EPA Figures Show Grim Pollution Realities on 40th Anniversary of Clean Water Act

JUDGE HALTS GE CROPS ON SOUTHEASTERN WILDLIFE REFUGES

Separate Ruling Leaves Door Ajar for GE Crops on Midwestern Refuges for Now

YELLOWSTONE’S NEW CELL TOWER PRE-APPROVED DESPITE IMPACTS

Disingenuous Call for Public Comments Does Not Cure Violations of Law and Policy

INVESTIGATION FAILS TO SORT OUT WEATHER SERVICE FISCAL SCANDAL

NOAA Casts Blame but Cannot Find Cause for Massive Budgetary Check Kiting

VOLUNTARY LIVESTOCK DRUG WITHDRAWAL PROSPECTS ILLUSORY

FDA Wishful Strategy of Corporate Cooperation to Stem Growing Drug Resistance